Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Core Scientific (CORZ) over the last 6 years, with Q3 2025 value amounting to $2.3 billion.

  • Core Scientific's Liabilities and Shareholders Equity rose 14906.19% to $2.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 billion, marking a year-over-year increase of 13363.08%. This contributed to the annual value of $1.6 billion for FY2024, which is 12450.35% up from last year.
  • Latest data reveals that Core Scientific reported Liabilities and Shareholders Equity of $2.3 billion as of Q3 2025, which was up 14906.19% from $2.0 billion recorded in Q2 2025.
  • Over the past 5 years, Core Scientific's Liabilities and Shareholders Equity peaked at $2.7 billion during Q1 2022, and registered a low of $347.1 million during Q3 2021.
  • In the last 5 years, Core Scientific's Liabilities and Shareholders Equity had a median value of $814.0 million in 2024 and averaged $1.2 billion.
  • In the last 5 years, Core Scientific's Liabilities and Shareholders Equity surged by 1625899333.33% in 2021 and then plummeted by 7189.33% in 2023.
  • Core Scientific's Liabilities and Shareholders Equity (Quarter) stood at $2.4 billion in 2021, then tumbled by 66.88% to $807.7 million in 2022, then fell by 11.83% to $712.2 million in 2023, then soared by 124.5% to $1.6 billion in 2024, then skyrocketed by 43.61% to $2.3 billion in 2025.
  • Its last three reported values are $2.3 billion in Q3 2025, $2.0 billion for Q2 2025, and $1.6 billion during Q1 2025.